- Creatine monohydrate is one of the most researched sports supplements, with consistent evidence supporting modest gains in muscle mass when combined with resistance training.
- It works primarily by replenishing phosphocreatine stores, allowing more total training volume — the actual driver of muscle growth.
- A loading phase is optional; 3–5 g daily reaches saturation within 3–4 weeks without it.
- It is generally safe for healthy adults, but certain populations should consult a clinician before starting.
What the evidence shows
The short answer: the evidence here is genuinely strong, which is unusual in the supplement world. Multiple meta-analyses — not just individual studies — consistently find that creatine monohydrate supplementation combined with resistance training produces greater lean mass gains than training alone.
A widely cited meta-analysis by Lanhers et al. (2017) examined creatine's effect on upper-body strength and found a significant benefit over placebo across 22 trials. Branch (2003) conducted a comprehensive meta-analysis of 100 studies and concluded that creatine supplementation produces small but reliable increases in fat-free mass (roughly 1–2 kg more than placebo over an 8–12 week training period). Rawson & Volek (2003) specifically looked at older adults and found measurable lean mass increases, suggesting the benefit is not limited to young, trained athletes.
It's worth being precise about what "muscle growth" means in these trials. Some of the early mass gain — especially in the first week — is intracellular water retention inside muscle cells (osmotic effect), not contractile protein. However, longer-duration studies (8 weeks and beyond) show genuine increases in muscle fiber cross-sectional area (Volek et al., 1999), suggesting true hypertrophy on top of the initial fluid shift. This is an important nuance: the number on the scale moves faster than the mirror does, at first.
Where the evidence is more mixed: creatine's benefit appears to be larger in people who are "low responders" — typically vegetarians or individuals with naturally low baseline muscle creatine stores (Burke et al., 2003). Meat-eaters who already have higher dietary creatine intake may see smaller marginal gains.
How it works (mechanism)
Creatine is stored in skeletal muscle as phosphocreatine. During short, high-intensity efforts (think a set of squats or a sprint), phosphocreatine rapidly donates a phosphate group to ADP to regenerate ATP — the cell's immediate energy currency. When phosphocreatine stores run out, power output falls and you hit fatigue sooner.
Supplementing creatine raises intramuscular phosphocreatine by roughly 20–40% (Greenhaff et al., 1994). More phosphocreatine means you can sustain high-intensity effort slightly longer — an extra rep or two per set. Over weeks and months of training, those extra reps compound into greater total training volume, which is the primary mechanical stimulus for muscle hypertrophy. Creatine does not directly build muscle; it lets you do more work, and that work builds muscle.
There is also emerging evidence for indirect anabolic effects — creatine may upregulate IGF-1 signaling and satellite cell activity (Olsen et al., 2006), and its osmotic effect on muscle cell volume may itself serve as a hypertrophic signal — but this mechanistic research is earlier-stage and should not be over-interpreted.
Dose & timing if you try it
Standard daily dose: 3–5 g of creatine monohydrate per day is the most robustly supported protocol. This is the dose used in the majority of clinical trials.
Loading phase (optional): Some protocols use 20 g/day split into four doses for 5–7 days to saturate muscle stores quickly, followed by 3–5 g/day for maintenance. Loading is not necessary — it just compresses the time to saturation from ~28 days to ~7 days. If you are not in a rush, skip the loading phase; it also reduces the chance of minor GI discomfort.
Timing: The science on timing is less conclusive than supplement marketing suggests. Some data hint that post-workout consumption may offer a small advantage (Antonio & Ciccone, 2013), but the difference is likely trivial compared to simply being consistent day-to-day. Taking it with a meal containing carbohydrates may enhance uptake slightly via insulin-mediated transport.
Form: Creatine monohydrate is the form used in virtually all the supporting research. There is no convincing evidence that more expensive forms (creatine HCl, buffered creatine, ethyl ester) are superior in practice. Stick with monohydrate.
Cycling: You do not need to cycle creatine. No evidence supports "washout" periods, and stopping supplementation simply returns your muscle creatine to baseline over a few weeks.
Who should skip
- People with pre-existing kidney disease: Creatine raises serum creatinine (a kidney filtration marker), which can confound lab interpretation and add stress to already-compromised kidneys. Anyone with reduced kidney function should not use creatine without explicit clinician approval.
- Pregnant or breastfeeding individuals: There is insufficient safety data for this population. Avoid until more is known.
- Children and adolescents: Most sports medicine organizations advise against creatine supplementation in those under 18, as long-term safety data are lacking and young athletes can gain strength through training alone.
- People on nephrotoxic medications: If you are taking drugs that are hard on kidneys (certain NSAIDs, antibiotics, or immunosuppressants), add the extra metabolic load of creatine only with your prescriber's guidance.
- Those prone to creatine non-response: Roughly 25–30% of people show minimal muscle creatine uptake regardless of dosing (Greenhaff et al., 1994). If you try it consistently for 8 weeks and notice no performance or body composition changes, you may be a non-responder — not everyone benefits equally.
Bottom line
Among sports supplements, creatine monohydrate stands out because the evidence actually matches the hype — mostly. It will not build muscle on its own, and the effect sizes are modest: expect roughly 1–2 kg more lean mass over a training cycle compared to training without it, not a transformation. But those are real, reproducible gains backed by decades of research in diverse populations.
If you resistance train consistently, eat enough protein, and want a supplement with a genuine evidence base, creatine monohydrate at 3–5 g/day is a reasonable addition. If you have kidney issues, are pregnant, or are under 18, skip it. And if the budget is tight, this is the one supplement in the gym bag that earns its keep.
References
- Antonio, J. & Ciccone, V. (2013). The effects of pre versus post workout supplementation of creatine monohydrate on body composition and strength. Journal of the International Society of Sports Nutrition, 10, 36.
- Branch, J. D. (2003). Effect of creatine supplementation on body composition and performance: a meta-analysis. International Journal of Sport Nutrition and Exercise Metabolism, 13(2), 198–226.
- Burke, D. G., et al. (2003). Effect of creatine and weight training on muscle creatine and performance in vegetarians. Medicine & Science in Sports & Exercise, 35(11), 1946–1955.
- Greenhaff, P. L., et al. (1994). Influence of oral creatine supplementation on muscle torque during repeated bouts of maximal voluntary exercise in man. Clinical Science, 87(3), 285–290.
- Lanhers, C., et al. (2017). Creatine supplementation and upper limb strength performance: a systematic review and meta-analysis. Sports Medicine, 47(1), 163–173.
- Olsen, S., et al. (2006). Creatine supplementation augments the increase in satellite cell and myonuclei number in human skeletal muscle induced by strength training. Journal of Physiology, 573(2), 525–534.
- Rawson, E. S. & Volek, J. S. (2003). Effects of creatine supplementation and resistance training on muscle strength and weightlifting performance. Journal of Strength and Conditioning Research, 17(4), 822–831.
- Volek, J. S., et al. (1999). Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Medicine & Science in Sports & Exercise, 31(8), 1147–1156.